Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about THERAPEUTIC_TARGET: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | THERAPEUTIC_TARGET |
graph TD
THERAPEUTIC_TARGET["THERAPEUTIC_TARGET"]
IDH2["IDH2"] -->|"target for"| THERAPEUTIC_TARGET
MTOR["MTOR"] -->|"target for"| THERAPEUTIC_TARGET
AQP4["AQP4"] -->|"target for"| THERAPEUTIC_TARGET
TGM2["TGM2"] -->|"target for"| THERAPEUTIC_TARGET
P2RX1["P2RX1"] -->|"target for"| THERAPEUTIC_TARGET
P2RX4["P2RX4"] -->|"target for"| THERAPEUTIC_TARGET
P2RX7["P2RX7"] -->|"target for"| THERAPEUTIC_TARGET
P2RY1["P2RY1"] -->|"target for"| THERAPEUTIC_TARGET| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| IDH2 | therapeutic_target | entity | 0.95 |
| P2RY11 | therapeutic_target | entity | 0.90 |
| P2RY14 | therapeutic_target | entity | 0.90 |
| TREM2 | therapeutic_target | gene | 0.90 |
| P2RX7 | therapeutic_target | entity | 0.90 |
| BCL-2 | therapeutic_target | protein | 0.90 |
| SOAT1 | therapeutic_target | entity | 0.90 |
| MTOR | therapeutic_target | entity | 0.90 |
| AQP4 | therapeutic_target | entity | 0.90 |
| TGM2 | therapeutic_target | entity | 0.90 |
| P2RX1 | therapeutic_target | entity | 0.90 |
| P2RX4 | therapeutic_target | entity | 0.90 |
| P2RY1 | therapeutic_target | entity | 0.90 |
| CTSB | involved_in | gene | 0.88 |
| EGFR | therapeutic_target | gene | 0.88 |
| PI3K | biomarker_for | protein | 0.88 |
| HCN1 | therapeutic_target | gene | 0.85 |
| PRMT1 | associated_with | entity | 0.85 |
| Hcrtr2 | therapeutic_target | protein | 0.85 |
| LNK | involved_in | protein | 0.85 |
| TGM2 | associated_with | gene | 0.85 |
| PPARG | associated_with | entity | 0.85 |
| SLC16A1 | therapeutic_target | entity | 0.85 |
| PANoptosome | therapeutic_target | process | 0.85 |
| HSPA5 | therapeutic_target | entity | 0.80 |
| PRKCG | targets | gene | 0.80 |
| Hcrtr1 | therapeutic_target | protein | 0.80 |
| FCGRT | therapeutic_target | entity | 0.80 |
| RAS | serves_as | protein | 0.80 |
| Plasma proteins | therapeutic_target | protein | 0.75 |
| DGAT1 | therapeutic_target | gene | 0.70 |
| BRAF | therapeutic_target | gene | 0.65 |
| SLC1A3 | therapeutic_target | gene | 0.60 |
| P2RY12 | therapeutic_target | gene | 0.60 |
| SORL1 | therapeutic_target | gene | 0.60 |
| SHIP1 | therapeutic_target | protein | 0.60 |
| P2RX7 | therapeutic_target | gene | 0.60 |
| APP | therapeutic_target | gene | 0.60 |
| CLU | therapeutic_target | gene | 0.60 |
| PSEN1 | therapeutic_target | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| TDP-43 condensation thermodynamics as a therapeutic target a | 0.710 | neuroscience | How can subcellular compartmentalization |
| CLU-APOE-TREM2 Tripartite Axis as a Coordinate Therapeutic T | 0.648 | neurodegeneration | Does clusterin exacerbate or protect aga |
| LPS-TLR4-NF-κB Signaling Cascade as Therapeutic Target | 0.594 | neurodegeneration | Gut-Brain Axis in Parkinson's Disease: M |
| Temporal cGAS-STING Activation Stage-Specific Therapeutic Ta | 0.560 | neuroinflammation | How does chronic cGAS/STING activation d |
| MAP6-mediated microtubule stabilization as therapeutic targe | 0.500 | neurodegeneration | View |
| AQP4 Water Channel Normalization as Surrogate Marker and The | 0.105 | neurodegeneration | Neuroinflammation Biomarker Panel for Ea |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Chrysophanol Attenuates Cognitive Impairment, Neuroinflammation, and Oxidative S [PMID:40728692] | Khan JZ, Zainab SR, Alattar A | Neurochem Res | 2025 | 0 |
| Qingda granule alleviates cerebral ischemia/reperfusion injury by inhibiting TLR [PMID:38184025] | Unknown | Journal of ethnopharmacology | 2024 | 0 |
| Ketogenic diet attenuates neuroinflammation and induces conversion of M1 microgl [PMID:37466915] | Sun W, Wang Q, Zhang R, Zhang N | Food & function | 2023 | 0 |
| NLRP3 inflammasome inhibition and M1-to-M2 microglial polarization shifting via [PMID:37137264] | Ibrahim Weam W; Skalicka-Woźniak K | International immunopharmacolo | 2023 | 0 |
| Microglia clear neuron-released α-synuclein via selective autophagy and prevent [PMID:32170061] | Choi I, Zhang Y, Seegobin SP | Nat Commun | 2020 | 0 |
| Lipocalin 2 induces neuroinflammation and blood-brain barrier dysfunction throug [PMID:32622362] | Mondal A, Bose D, Saha P | J Neuroinflammation | 2020 | 0 |
| RETRACTED: Hesperetin, a Citrus Flavonoid, Attenuates LPS-Induced Neuroinflammat [PMID:30884890] | ["Muhammad T", "Ikram M", "Ullah R", "Re | Nutrients | 2019 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning THERAPEUTIC_TARGET in their description or question text